Elisabeth J.M. Zirkzee
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Elisabeth J.M. Zirkzee has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
Gerda M. Steup-Beekman
Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands
2 shared publicationsA. A. Schouffoer
Leiden University Medical Center
1 shared publicationAzita Sohrabian
Department of Immunology, Genetics, and Pathology, Uppsala University, Uppsala, Sweden
1 shared publication- César Magro-Checa
Department of Rheumatology, Zuyderland Medical Center Heerlen Netherlands
1 shared publication Eduard L.E.M. Bollen
1 shared publicationEsther Baptist
1 shared publication
Latest Publications
- 1 August 2014
- Published by The Journal of Rheumatology in The Journal of Rheumatology
- Vol. 41 (8) , 1720-1721
Cluster Analysis of an Array of Autoantibodies in Neuropsychiatric Systemic Lupus Erythematosus
To the Editor: Neuropsychiatric symptoms in patients with systemic lupus erythematosus (SLE) present a challenge to the clinician because they can be caused by the underlying disease (neuropsychiatric SLE; NPSLE) or coexist independently1. No specific diagnostic test is available for NPSLE. Reports on the associations between specific antinuclear autoantibodies and distinct NPSLE syndromes have been conflicting2,3,4,5, perhaps because of the laboratory tests used to detect these autoantibodies. New multiplex technologies for the detection of autoantibodies have emerged in the last years and might be helpful in diagnosing NPSLE. We hypothesized that a cluster of autoantibodies could be associated with a specific NPSLE syndrome or with focal or diffuse NPSLE manifestations. Therefore we used an addressable laser bead immunoassay test in patients who visited the NPSLE clinic in Leiden, the Netherlands, a tertiary referral center for patients with SLE who have neuropsychiatric symptoms. Between September 2007 and February 2012, 133 patients with SLE who had neuropsychiatric symptoms were evaluated and diagnosed consecutively by a multidisciplinary team6. All patients fulfilled the revised SLE criteria of the American College … Address correspondence to Dr. E.J.M. Zirkzee, Department of Rheumatology, Leiden University Medical Center, PO Box 9600, 2300 RC Leiden, The Netherlands. E-mail: E.J.M.Zirkzee{at}LUMC.nl
- 1 August 2014
- Published by The Journal of Rheumatology in The Journal of Rheumatology
- Vol. 41 (8) , 1720-1721
Cluster Analysis of an Array of Autoantibodies in Neuropsychiatric Systemic Lupus Erythematosus
To the Editor: Neuropsychiatric symptoms in patients with systemic lupus erythematosus (SLE) present a challenge to the clinician because they can be caused by the underlying disease (neuropsychiatric SLE; NPSLE) or coexist independently1. No specific diagnostic test is available for NPSLE. Reports on the associations between specific antinuclear autoantibodies and distinct NPSLE syndromes have been conflicting2,3,4,5, perhaps because of the laboratory tests used to detect these autoantibodies. New multiplex technologies for the detection of autoantibodies have emerged in the last years and might be helpful in diagnosing NPSLE. We hypothesized that a cluster of autoantibodies could be associated with a specific NPSLE syndrome or with focal or diffuse NPSLE manifestations. Therefore we used an addressable laser bead immunoassay test in patients who visited the NPSLE clinic in Leiden, the Netherlands, a tertiary referral center for patients with SLE who have neuropsychiatric symptoms. Between September 2007 and February 2012, 133 patients with SLE who had neuropsychiatric symptoms were evaluated and diagnosed consecutively by a multidisciplinary team6. All patients fulfilled the revised SLE criteria of the American College … Address correspondence to Dr. E.J.M. Zirkzee, Department of Rheumatology, Leiden University Medical Center, PO Box 9600, 2300 RC Leiden, The Netherlands. E-mail: E.J.M.Zirkzee{at}LUMC.nl
- 18 April 2014
- Published by Springer Nature in Clinical Rheumatology
- Vol. 33 (9) , 1279-1287
Health care in systemic lupus erythematosus (SLE): the patient’s perspective
In order to provide more patient-centered care for patients suffering from systemic lupus erythematosus (SLE), we studied their current satisfaction and preferences regarding future health care delivery. We sent questionnaires to all SLE patients visiting the rheumatology outpatient clinic in Leiden, the Netherlands. The questionnaire comprised three topics: (a) health care needs using a modified version of SLE Needs Questionnaire (range 0–38), (b) satisfaction with care per provider (visual analogue scale, range 0 (not at all)–100 (very satisfied)), and (c) preferences for future healthcare (four items). One hundred and two patients (63 % response) reported an average of 16 (±6) health care needs, with all patients reporting a need in the physical domain. More needs were significantly associated with worse physical functioning and a higher educational level. The average satisfaction score was 73 (±19) with a lower overall satisfaction score being associated with younger age and an educational level higher or lower than average. Regarding preferences for future health care delivery, 75 % of patients showed interest in a yearly standardized medical assessment, 57 % in regular, specialized nurse contacts using internet, 50 % in a yearly inventory on the need for self-management support, and 36 % in an education course. The association of age, education level and physical functioning with health care needs, and/or satisfaction suggest that the delivery of care should be better tailored to the needs of subgroups of patients.
- 18 April 2014
- Published by Springer Nature in Clinical Rheumatology
- Vol. 33 (9) , 1279-1287
Health care in systemic lupus erythematosus (SLE): the patient’s perspective
In order to provide more patient-centered care for patients suffering from systemic lupus erythematosus (SLE), we studied their current satisfaction and preferences regarding future health care delivery. We sent questionnaires to all SLE patients visiting the rheumatology outpatient clinic in Leiden, the Netherlands. The questionnaire comprised three topics: (a) health care needs using a modified version of SLE Needs Questionnaire (range 0–38), (b) satisfaction with care per provider (visual analogue scale, range 0 (not at all)–100 (very satisfied)), and (c) preferences for future healthcare (four items). One hundred and two patients (63 % response) reported an average of 16 (±6) health care needs, with all patients reporting a need in the physical domain. More needs were significantly associated with worse physical functioning and a higher educational level. The average satisfaction score was 73 (±19) with a lower overall satisfaction score being associated with younger age and an educational level higher or lower than average. Regarding preferences for future health care delivery, 75 % of patients showed interest in a yearly standardized medical assessment, 57 % in regular, specialized nurse contacts using internet, 50 % in a yearly inventory on the need for self-management support, and 36 % in an education course. The association of age, education level and physical functioning with health care needs, and/or satisfaction suggest that the delivery of care should be better tailored to the needs of subgroups of patients.
- 1 February 2013
- Published by The Journal of Rheumatology in The Journal of Rheumatology
- Vol. 40 (2) , 204.2-204
Dr. Zirkzee, et al reply
- 1 February 2013
- Published by The Journal of Rheumatology in The Journal of Rheumatology
- Vol. 40 (2) , 204.2-204
Dr. Zirkzee, et al reply
- 15 September 2012
- Published by The Journal of Rheumatology in The Journal of Rheumatology
- Vol. 39 (11) , 2118-2126
Prospective Study of Clinical Phenotypes in Neuropsychiatric Systemic Lupus Erythematosus; Multidisciplinary Approach to Diagnosis and Therapy
Objective. To describe clinical phenotypes in neuropsychiatric systemic lupus erythematosus (NPSLE). Methods. Data were prospectively collected in the Leiden NPSLE referral clinic, where patients suspected of having NPSLE are assessed in a standardized multidisciplinary manner. In consensus meetings, all medical specialists agreed on therapeutic strategy based on the suspected pathogenetic mechanism of NPSLE in the individual patient. An algorithm illustrates the process of decision-making during the consensus meeting. Clinical phenotypes are described, classified by pathogenetic mechanism. Results. One hundred consecutive patients were evaluated, of whom 71 had SLE (29 patients did not fulfill ≥ 4 American College of Rheumatology criteria) and 46 had NPSLE. Primary NPSLE was diagnosed in 38 patients (53%) and could be differentiated in 21 patients (55%) with inflammatory NPSLE who were advised on immunosuppressive therapy, 12 patients (32%) with ischemic NPSLE who were advised on anticoagulant therapy, and 5 patients (13%) with undefined NPSLE who were advised symptomatic treatment only. Cognitive dysfunction and higher level of disease activity were associated with inflammatory NPSLE. Although presence of immunoglobulin G anticardiolipin antibodies and abnormalities on magnetic resonance imaging (MRI) were associated with ischemic NPSLE, abnormalities on MRI lacked specificity to distinguish phenotypes. A history of renal disease and use of corticosteroids were associated with secondary NPSLE. Conclusion. We describe multidisciplinary consensus as a standard for diagnosing and defining phenotypes in NPSLE. These phenotypes show specific characteristics, which can be used to support diagnosis and guide therapeutic decisions. Clinical phenotyping and selection of patients becomes increasingly important when advances in experimental science lead to new targets for therapy in NPSLE.
- 15 September 2012
- Published by The Journal of Rheumatology in The Journal of Rheumatology
- Vol. 39 (11) , 2118-2126
Prospective Study of Clinical Phenotypes in Neuropsychiatric Systemic Lupus Erythematosus; Multidisciplinary Approach to Diagnosis and Therapy
Objective. To describe clinical phenotypes in neuropsychiatric systemic lupus erythematosus (NPSLE). Methods. Data were prospectively collected in the Leiden NPSLE referral clinic, where patients suspected of having NPSLE are assessed in a standardized multidisciplinary manner. In consensus meetings, all medical specialists agreed on therapeutic strategy based on the suspected pathogenetic mechanism of NPSLE in the individual patient. An algorithm illustrates the process of decision-making during the consensus meeting. Clinical phenotypes are described, classified by pathogenetic mechanism. Results. One hundred consecutive patients were evaluated, of whom 71 had SLE (29 patients did not fulfill ≥ 4 American College of Rheumatology criteria) and 46 had NPSLE. Primary NPSLE was diagnosed in 38 patients (53%) and could be differentiated in 21 patients (55%) with inflammatory NPSLE who were advised on immunosuppressive therapy, 12 patients (32%) with ischemic NPSLE who were advised on anticoagulant therapy, and 5 patients (13%) with undefined NPSLE who were advised symptomatic treatment only. Cognitive dysfunction and higher level of disease activity were associated with inflammatory NPSLE. Although presence of immunoglobulin G anticardiolipin antibodies and abnormalities on magnetic resonance imaging (MRI) were associated with ischemic NPSLE, abnormalities on MRI lacked specificity to distinguish phenotypes. A history of renal disease and use of corticosteroids were associated with secondary NPSLE. Conclusion. We describe multidisciplinary consensus as a standard for diagnosing and defining phenotypes in NPSLE. These phenotypes show specific characteristics, which can be used to support diagnosis and guide therapeutic decisions. Clinical phenotyping and selection of patients becomes increasingly important when advances in experimental science lead to new targets for therapy in NPSLE.